The lymphoproliferative response to enzymatically digested gelatin in subjects with gelatin hypersensitivity

This study was designed to evaluate the immunogenic characteristics of enzymatically digested gelatin, ‘FreAlagin’, employing the lymphoproliferative response in subjects with gelatin hypersensitivity. Our purpose was to assess the response of primed lymphocytes to the newly developed FreAlagin and compare it to the response to conventional gelatin.

[1]  T. Okui,et al.  Gelatin-containing diphtheria-tetanus-pertussis (DTP) vaccine causes sensitization to gelatin in the recipients. , 2000, Vaccine.

[2]  M. Sakaguchi,et al.  A case of anaphylaxis to gelatin included in erythropoietin products. , 1999, The Journal of allergy and clinical immunology.

[3]  Y. Sakai,et al.  Non-antigenic and low allergic gelatin produced by specific digestion with an enzyme-coupled matrix. , 1998, Biological & pharmaceutical bulletin.

[4]  M. Sakaguchi,et al.  Gelatin-specific humoral and cellular immune responses in children with immediate- and nonimmediate-type reactions to live measles, mumps, rubella, and varicella vaccines. , 1997, The Journal of allergy and clinical immunology.

[5]  M. Sakaguchi,et al.  Development of IgE antibody to gelatin in children with systemic immediate-type reactions to vaccines. , 1997, The Journal of allergy and clinical immunology.

[6]  M. Sakaguchi,et al.  IgE-mediated systemic reactions to gelatin included in the varicella vaccine. , 1997, The Journal of allergy and clinical immunology.

[7]  M. Sakaguchi,et al.  Systemic immediate-type reactions to gelatin included in Japanese encephalitis vaccines. , 1997, Vaccine.

[8]  M. Sakaguchi,et al.  IgE antibody to gelatin in children with immediate-type reactions to measles and mumps vaccines. , 1995, The Journal of allergy and clinical immunology.

[9]  J. Kelso,et al.  Anaphylaxis to measles, mumps, and rubella vaccine mediated by IgE to gelatin. , 1993, The Journal of allergy and clinical immunology.

[10]  A. Zuckerman,et al.  Stability of further-attenuated measles vaccines. , 1983, Reviews of infectious diseases.

[11]  M. Hilleman,et al.  Stability on storage at various temperatures of live measles, mumps and rubella virus vaccines in new stabilizer. , 1980, Journal of biological standardization.